Clinical Study

Xyloglucan for the Treatment of Acute Gastroenteritis in Children: Results of a Randomized, Controlled, Clinical Trial

Table 1

Baseline demographic and clinical characteristics of children.

Statistical variableXyloglucan + ORS ()ORS ()Total ()

Gender (girls) (%)9 (50.00)12 (66.67)21 (58.33)
Age (years)Mean (SD)4.72 (4.33)3.94 (3.26)4.33 (3.80)
Age ranges (%)
 ≤1 year3 (16.67)2 (11.11)5 (13.88)
 1–5 years7 (38.89)10 (55.56)17 (47.22)
 5–10 years4 (22.22)5 (27.78)9 (25.00)
 >10 years4 (22.22)1 (5.56)5 (13.88)
Hydration status (%)
 Normal11 (61.11)13 (72.22)24 (66.66)
 Mild dehydration7 (38.89)5 (27.78)12 (33.33)
Body temperature
 ≤37°C9 (50.00)7 (38.89)16 (44.44)
 37-38°C5 (27.78)6 (33.33)11 (30.55)
 >38°C4 (22.22)5 (27.78)9 (25.00)

ORS: oral rehydration solution; SD: standard deviation.